Back
Novo Nordisk A/S Vs. Eli Lilly and Industry Stock Comparison
Buy
74
NONOF
Novo Nordisk A/S
Last Price:
132.41
Seasonality Move:
3.75%
Buy
64
LLY
Eli Lilly and
Last Price:
770.79
Seasonality Move:
1.62%
Buy
74
Novo Nordisk A/S (NONOF)
is a Buy
Is Novo Nordisk A/S a Buy, Sell or Hold?
- The current Novo Nordisk A/S [NONOF] share price is $132.41. The Score for NONOF is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
- NONOF is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
64
Eli Lilly and (LLY)
is a Buy
Is Eli Lilly and a Buy, Sell or Hold?
- The current Eli Lilly and [LLY] share price is $770.00. The Score for LLY is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
- LLY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NONOF Stock Price Chart
What is Novo Nordisk A/S's stock price today?
-
The Novo Nordisk A/S share price today is $132.41
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NONOF is experiencing slight buying pressure.
LLY Stock Price Chart
What is Eli Lilly and's stock price today?
-
The Eli Lilly and share price today is $770.00
The current trend is moderately bullish and LLY is experiencing slight selling pressure.
NONOF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.8 | Buy |
| Relative Strength Index (14 RSI): | 60.7 | Buy |
| Chaikin Money Flow: | 1155 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (123.15 - 130.13) | Buy |
| Bollinger Bands (100): | (111.29 - 130.35) | Buy |
LLY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.96 | Buy |
| Relative Strength Index (14 RSI): | 53.03 | Buy |
| Chaikin Money Flow: | -418938 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (736.7 - 773.3) | Buy |
| Bollinger Bands (100): | (659.62 - 785.64) | Buy |
NONOF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 130.61 | Buy |
| 20-day SMA: | 127.49 | Buy |
| 50-day SMA: | 127.65 | Buy |
| 200-day SMA: | 108.43 | Buy |
| 8-day EMA: | 130.75 | Buy |
| 20-day EMA: | 128.38 | Buy |
| 50-day EMA: | 125.92 | Buy |
| 200-day EMA: | 110.08 | Buy |
LLY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 769.55 | Buy |
| 20-day SMA: | 757.72 | Buy |
| 50-day SMA: | 760.26 | Buy |
| 200-day SMA: | 646 | Buy |
| 8-day EMA: | 769 | Buy |
| 20-day EMA: | 763.13 | Buy |
| 50-day EMA: | 752.61 | Buy |
| 200-day EMA: | 651.12 | Buy |
Novo Nordisk A/S Earnings Growth & NONOF Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.52 per share, and an increase next year of $0.55 per share.
Eli Lilly and Earnings Growth & LLY Earnings Dates
- Analysts estimate an earnings increase this quarter of $3.91 per share, an increase next quarter of $0.07 per share, an increase this year of $7.48 per share, and an increase next year of $5.24 per share.
Novo Nordisk A/S Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Eli Lilly and Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||